Patents by Inventor Tomasz RADON

Tomasz RADON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers for pancreatic cancer
    Patent number: 11977077
    Abstract: The present invention relates to pancreatic cancers and the use of biomarkers in biological samples for the diagnosis of such conditions, in particular pancreatic ductal adenocarcinoma. The biomarker panel comprises LYVE1, REG1 and TFF1. Methods of treatment are also provided, as well as kits useful in the diagnosis and treatment of pancreatic ductal adenocarcinoma. The present invention is particularly useful in detecting early-stage PDAC.
    Type: Grant
    Filed: August 26, 2020
    Date of Patent: May 7, 2024
    Assignee: Queen Mary University of London
    Inventors: Tatjana Crnogorac-Jurcevic, Tomasz Radon
  • BIOMARKERS FOR PANCREATIC CANCER
    Publication number: 20220042998
    Abstract: The present invention relates to pancreatic cancers and the use of biomarkers in biological samples for the diagnosis of such conditions, in particular pancreatic ductal adenocarcinoma. The biomarker panel comprises LYVE1, REG1 and TFF1. Methods of treatment are also provided, as well as kits useful in the diagnosis and treatment of pancreatic ductal adenocarcinoma. The present invention is particularly useful in detecting early-stage PDAC.
    Type: Application
    Filed: August 26, 2020
    Publication date: February 10, 2022
    Applicant: Queen Mary University of London
    Inventors: Tatjana CRNOGORAC-JURCEVIC, Tomasz RADON
  • Biomarkers for pancreatic cancer
    Patent number: 10782301
    Abstract: The present invention relates to pancreatic cancers and the use of biomarkers in biological samples for the diagnosis of such conditions, in particular pancreatic ductal adenocarcinoma. The biomarker panel comprises LYVE1, REG1 and TFF1. Methods of treatment arc also provided, as well as kits useful in the diagnosis and treatment of pancreatic ductal adenocarcinoma. The present invention is particularly useful in detecting early-stage PDAC.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: September 22, 2020
    Assignee: Queen Mary University of London
    Inventors: Tatjana Crnogorac-Jurcevic, Tomasz Radon
  • BIOMARKERS FOR PANCREATIC CANCER
    Publication number: 20190204323
    Abstract: The present invention relates to pancreatic cancers and the use of biomarkers in biological samples for the diagnosis of such conditions, in particular pancreatic ductal adenocarcinoma. The biomarker panel comprises LYVE1, REG1 and TFF1. Methods of treatment are also provided, as well as kits useful in the diagnosis and treatment of pancreatic ductal adenocarcinoma. The present invention is particularly useful in detecting early-stage PDAC.
    Type: Application
    Filed: February 5, 2016
    Publication date: July 4, 2019
    Applicant: Queen Mary University of London
    Inventors: Tatjana CRNOGORAC-JURCEVIC, Tomasz RADON